Pre-operative growth differentiation factor 15 as a novel biomarker of acute kidney injury after cardiac bypass surgery. (15th October 2015)

• Record Type: Journal Article
• Authors: Guenancia, Charles; Kahli, Abdelkader; Laurent, Gabriel; Hachet, Olivier; Malapert, Ghislain; Grosjean, Sandrine; Girard, Claude; Vergely, Catherine; Bouchot, Olivier
• Is Part Of: International journal of cardiology. Volume 197(2015)
• Page Start: 66
• Page End: 71
• Publication Date: 2015-10-15
• Subjects: AKI acute kidney injury -- AF atrial fibrillation -- CABG coronary artery bypass graft surgery -- CBP cardiopulmonary bypass -- CRS cardio renal syndrome -- eGFR estimated glomerular filtration rate -- GDF-15 growth differentiation factor 15 -- HBP high blood pressure -- ICU intensive care unit -- IND induction of anesthesia -- LA left atrial -- LVEF left ventricular ejection fraction -- NGAL neutrophil gelatinase-associated lipocalin -- NT-proBNP N terminal pro brain natriuretic peptide -- OFP off-pump surgery -- ONP on-pump surgery -- RRT renal replacement therapy -- SCr serum creatinine; GDF-15 -- Acute kidney injury -- Cardiopulmonary bypass -- Risk stratification -- Off-pump -- Cardiac surgery; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2015.06.012
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Background: Pre-operative GDF-15 plasma levels significantly improve the prognostic value of the EuroSCORE for mortality after cardiac surgery. However, despite the strong correlation between GDF-15 and renal function, no data are available regarding the potential interest of pre-operative GDF-15 levels to improve the prediction of acute kidney injury (AKI) after cardiac artery bypass graft (CABG) surgery. Methods: All patients operated on by 2 surgeons for CABG surgery at our university hospital from September 2011 to March 2013 were screened for participation in this prospective, observational study. Exclusion criteria: age < 18 years or > 80 years, previous atrial fibrillation/flutter, previous severe renal failure, previous cardiac surgery, emergency surgery. AKI was defined according to KDIGO criteria. GDF-15 levels in plasma were measured before induction and 12 h after surgery. Results: 134 patients were included in this study. 42 (31%) developed post-operative AKI. AKI patients had a significantly higher pre-operative log-GDF-15 level (OR = 3.64; 95% CI = 1.41–9.40, p = 0.008), a lower pre-operative eGFR (OR = 0.98; 95% CI = 0.96–0.99; p = 0.026), and most often underwent on-pump surgery (OR = 2.60; 95% CI = 1.14–5.96, p = 0.024). On ROC curves, GDF-15 before induction was found to be the best pre-operative biomarker to predict AKI (AUC = 0.83; CI = 0.75–0.89), compared with eGFR (AUC = 0.67; 95% CI = 0.59–0.75), p = 0.003 and NT-proBNP (AUC = 0.62; CI = 0.51–0.72), p < 0.001. Pre-operative GDF-15 was also significantly better than the EuroSCORE in predicting AKI (AUC 0.62, 95% CI = 0.54–0.70), p < 0.001. Conclusions: Pre-operative GDF-15 plasma levels are associated with post-operative AKI in CABG patients. If confirmed in larger cohorts, pre-operative GDF-15 may be of value to improve pre-operative risk stratification among candidates for surgery.